174 related articles for article (PubMed ID: 36320323)
1. miR-196a enhances polymerization of neuronal microfilaments through suppressing IMP3 and upregulating IGF2 in Huntington's disease.
Yang HI; Huang PY; Chan SC; Tung CW; Cheng PH; Chen CM; Yang SH
Mol Ther Nucleic Acids; 2022 Dec; 30():286-299. PubMed ID: 36320323
[TBL] [Abstract][Full Text] [Related]
2. miR-196a Enhances Neuronal Morphology through Suppressing RANBP10 to Provide Neuroprotection in Huntington's Disease.
Her LS; Mao SH; Chang CY; Cheng PH; Chang YF; Yang HI; Chen CM; Yang SH
Theranostics; 2017; 7(9):2452-2462. PubMed ID: 28744327
[TBL] [Abstract][Full Text] [Related]
3. The Potential Regulatory Mechanisms of miR-196a in Huntington's Disease through Bioinformatic Analyses.
Fu MH; Li CL; Lin HL; Tsai SJ; Lai YY; Chang YF; Cheng PH; Chen CM; Yang SH
PLoS One; 2015; 10(9):e0137637. PubMed ID: 26376480
[TBL] [Abstract][Full Text] [Related]
4. miR-196a provides antioxidative neuroprotection via USP15/Nrf2 regulation in Huntington's disease.
Chan SC; Tung CW; Lin CW; Tung YS; Wu PM; Cheng PH; Chen CM; Yang SH
Free Radic Biol Med; 2023 Nov; 209(Pt 2):292-300. PubMed ID: 37907121
[TBL] [Abstract][Full Text] [Related]
5. miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models.
Cheng PH; Li CL; Chang YF; Tsai SJ; Lai YY; Chan AW; Chen CM; Yang SH
Am J Hum Genet; 2013 Aug; 93(2):306-12. PubMed ID: 23810380
[TBL] [Abstract][Full Text] [Related]
6. miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells.
Kunkanjanawan T; Carter RL; Prucha MS; Yang J; Parnpai R; Chan AW
PLoS One; 2016; 11(9):e0162788. PubMed ID: 27631085
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.
Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH
PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208
[TBL] [Abstract][Full Text] [Related]
8. FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cells.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
Life Sci; 2021 Feb; 267():118952. PubMed ID: 33383048
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease Models.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
Mol Neurobiol; 2021 May; 58(5):2396-2406. PubMed ID: 33421017
[TBL] [Abstract][Full Text] [Related]
10. High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.
Szarvas T; vom Dorp F; Niedworok C; Melchior-Becker A; Fischer JW; Singer BB; Reis H; Bánkfalvi Á; Schmid KW; Romics I; Ergün S; Rübben H
BJU Int; 2012 Sep; 110(6 Pt B):E308-17. PubMed ID: 22500655
[TBL] [Abstract][Full Text] [Related]
11. Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis.
Zhang K; Zhou M; Chen H; Wu G; Chen K; Yang H
Clin Transl Oncol; 2015 Jul; 17(7):570-5. PubMed ID: 25740666
[TBL] [Abstract][Full Text] [Related]
12. The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis.
Chen P; Wang SJ; Wang HB; Ren P; Wang XQ; Liu WG; Gu WL; Li DQ; Zhang TG; Zhou CJ
J Mol Histol; 2012 Feb; 43(1):63-70. PubMed ID: 22042095
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic analysis of a microRNA regulatory network in Huntington's disease.
Wang ZM; Dong XY; Cong SY
J Integr Neurosci; 2020 Dec; 19(4):641-650. PubMed ID: 33378838
[TBL] [Abstract][Full Text] [Related]
14. Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth
Huang S; Ge X; Yu J; Han Z; Yin Z; Li Y; Chen F; Wang H; Zhang J; Lei P
FASEB J; 2018 Jan; 32(1):512-528. PubMed ID: 28935818
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation.
Yu JY; Chung KH; Deo M; Thompson RC; Turner DL
Exp Cell Res; 2008 Aug; 314(14):2618-33. PubMed ID: 18619591
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.
Chang KH; Wu YR; Chen CM
Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536
[TBL] [Abstract][Full Text] [Related]
17. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
18. Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain.
Fukuoka M; Takahashi M; Fujita H; Chiyo T; Popiel HA; Watanabe S; Furuya H; Murata M; Wada K; Okada T; Nagai Y; Hohjoh H
Mol Ther Nucleic Acids; 2018 Jun; 11():79-90. PubMed ID: 29858092
[TBL] [Abstract][Full Text] [Related]
19. TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs.
Weng YT; Chen HM; Chien T; Chiu FL; Kuo HC; Chern Y
Mov Disord; 2022 Oct; 37(10):2008-2020. PubMed ID: 35997316
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
Liu XH; Lu KH; Wang KM; Sun M; Zhang EB; Yang JS; Yin DD; Liu ZL; Zhou J; Liu ZJ; De W; Wang ZX
BMC Cancer; 2012 Aug; 12():348. PubMed ID: 22876840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
